Modulation of Patient-Derived Tumor Organoids by SARS-CoV-2 Variants Across Cancer Types - A Study Combining Morphology, Inflammation, and Whole-Exome Profiling
Favorite
Share
More Options
22

Open in WPS to view all 22 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
